Table 6.
Placebo (n=2032) | Zinc (n=2038) | RR (95% CI) | |
---|---|---|---|
Diarrhoea | |||
>1 | 953 (47%) | 997 (49%) | 1·03 (0·94−1·14) |
>2 | 661 (33%) | 641 (31%) | 0·97 (0·85−1·10) |
>3 | 422 (21%) | 397 (19%) | 0·93 (0·79−1·10) |
>4 | 269 (13%) | 269 (13%) | 0·98 (0·80−1·20) |
Persistent diarrhoea | |||
>1 | 8 (<1%) | 7 (<1%) | 0·87 (0·32−2·36) |
Dysentery | |||
>1 | 73 (4%) | 88 (4%) | 1·27 (0·85−1·89) |
>2 | 20 (1%) | 27 (1%) | 1·33 (0·70−2·51) |
ALRI | |||
>1 | 459 (23%) | 480 (24%) | 1·04 (0·89−1·22) |
>2 | 226 (11%) | 257 (13%) | 1·14 (0·91−1·43) |
>3 | 102 (5%) | 131 (6%) | 1·26 (0·91−1·74) |
Data are n (%). RR=relative risk. ALRI=acute lower respiratory illness.